Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 12, 2024 (Week 41) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 21 NC 3,394 5,276 New England - NC 51 81 Connecticut - NC - - Maine - NC 11 37 Massachusetts - NC - - New Hampshire - NC 14 20 Rhode Island - NC 25 23 Vermont - NC 1 1 Middle Atlantic 2 NC 122 447 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 188 Pennsylvania 2 NC 122 259 East North Central 14 NC 1,612 2,138 Illinois - NC 28 581 Indiana - NC 213 296 Michigan - NC 149 264 Ohio 14 NC 1,101 962 Wisconsin - NC 121 35 West North Central - NC 124 213 Iowa - NC 50 71 Kansas - NC 68 68 Minnesota - NC - 61 Missouri - NC - - Nebraska - NC - - North Dakota - NC - 11 South Dakota - NC 6 2 South Atlantic 5 NC 446 668 Delaware - NC 15 12 District of Columbia - NC - - Florida N NC N N Georgia - NC - 250 Maryland - NC - - North Carolina - NC - 135 South Carolina - NC - - Virginia 5 NC 354 198 West Virginia - NC 77 73 East South Central - NC 69 174 Alabama N NC N N Kentucky - NC - - Mississippi - NC 69 174 Tennessee - NC - - West South Central - NC - 19 Arkansas - NC - - Louisiana - NC - 19 Oklahoma - NC - - Texas U NC U U Mountain - NC 953 793 Arizona - NC 904 644 Colorado - NC - - Idaho - NC - - Montana - NC 8 1 Nevada - NC 2 87 New Mexico - NC - - Utah - NC 39 60 Wyoming - NC - 1 Pacific - NC 17 743 Alaska - NC - - California - NC - 637 Hawaii - NC - 16 Oregon - NC 17 22 Washington - NC - 68 U.S. Territories - NC - 141 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 141 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC 2 - Total 21 NC 3,396 5,417 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.